To access full text you may have to log in to your NHS Athens account (click here to register for free). If full text is not available then please email us to request a copy.
Do you have any research needs? Please do contact your Cardiac Surgery Librarian, Keith Nockels for any information and research assistance. Keith can be contacted directly on 0116 258 5558 or via email at: keith.nockels@uhl-tr.nhs.uk
Stable angina: management (CG126) - surveillance decision: NICE has decided after the new evidence that no update is necessary for this guideline. However, NICE will amend the guideline to include a footnote to the recommendations for third line drug treatments.
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope Authors' conclusions: Our systematic review shows that there is no evidence that an ILR-based diagnostic strategy reduces long-term mortality as compared to a standard diagnostic assessment (very low quality evidence). No data were available for short-term all-cause mortality. Moderate quality evidence shows that an ILR-based diagnostic strategy increases the rate of aetiologic diagnosis as compared to a standard diagnostic pathway. No conclusive data were available on the other end-points analysed.
Further trials evaluating the effect of ILRs in the diagnostic strategy of people with recurrent unexplained syncope are warranted. Future research should focus on the assessment of the ability of ILRs to change clinically relevant outcomes, such as quality of life, syncope relapse and costs.
Exercise-based cardiac rehabilitation for adults after heart valve surgery Authors' conclusions: Our findings suggest that exercise-based rehabilitation for adults after heart valve surgery, compared with no exercise, may improve exercise capacity. Due to a lack of evidence, we cannot evaluate the impact on other outcomes. Further high-quality randomised clinical trials are needed in order to assess the impact of exercise-based rehabilitation on patient-relevant outcomes, including mortality and quality of life.
Revascularization for acute coronary syndromes
Updated 2016 Apr 11 08:18:00 AM: invasive treatment strategy including early assessment by coronary angiography may reduce myocardial infarction and urgent revascularization in patients ≥ 80 years old hospitalized with non-ST-elevation myocardial infarction or unstable angina (Lancet 2016 Jan 12 early online) view update
Antiplatelet and anticoagulant drugs for elective percutaneous coronary intervention (PCI)
Updated 2016 Apr 11 06:54:00 AM: extended dual antiplatelet therapy with aspirin plus P2Y12 inhibitor may reduce risk of major adverse cardiovascular events, but may increase risk of major bleeding compared to aspirin alone in patients with prior myocardial infarction (Eur Heart J 2016 Jan 21) view update
Other Good Quality Systematic Reviews and Articles
National Congenital Heart Disease audit report 2012‐15
The Healthcare Quality Improvement Partnership has published the National Congenital Heart Disease Audit 2012-2015. The report shows survival for children undergoing cardiac procedures for congenital heart disease has continued to improve in recent years. It also shows that antenatal detection rates continue to improve.
Acute coronary syndrome guidance
The Scottish Intercollegiate Guidelines Network, Healthcare Improvement network has published Acute coronary syndrome guideline 148. This guideline provides recommendations on the management of patients with acute coronary syndrome. It covers presentation, assessment and diagnosis, initial management, reperfusion therapy, risk stratification and non-invasive testing, invasive investigation and revascularisation, early pharmacological intervention and treatment of hypoxia and cardiogenic shock and includes a checklist of information for patients
NHS Behind the Headlines - media stories explained
